Meyer Cancer Center

Learn more about Alex Trebek’s pancreatic cancer update from Dr. Allyson Ocean, a GI oncologist at NewYork-Presbyterian Hospital Meyer Cancer Center, in which s...he highlights the role of chemotherapy advancements and why patients should undergo genetic testing. http://ow.ly/NgF930oR4Gz via MensHealth See more

Meyer Cancer Center investigators, Ekta Khurana, Ph.D. and Effie Apostolou, Ph.D., recently published a new study on Identification of Cancer Drivers at CTCF Insulators in 1,962 Whole Genomes in Cell Systems. Their development of a computational method to analyze somatic mutations reveals several CTCF insulators as putative cancer drivers. Weill Cornell Medicine

In recognition of #ColonCancerAwarenessMonth, Weill Cornell Medicine/NewYork-Presbyterian Hospital faculty and nursing staff will be available to explain new screening guidelines, treatment options and answer questions about colon cancer. Visit their information table to find out more. Date: March 18 - 20 Time: 11am - 2pm Location: WCM/NYP Garden Café Vending Area (F-0-09)... Date: March 21 - 22 Time: 11am - 2pm Location: David H. Koch Center, 7th Floor Lounge (DHK-07-762)

Ekta Khurana, Ph.D., Assistant Professor of Computational Genomics, Physiology and Biophysics and Computational Genomics in Computational Biomedicine recently received the Irma T. Hirschl/Monique Weill-Caulier Scholar Award for her project, Using Chromatin Conformation Changes at Single-cell Level to Identify Drivers of Treatment Resistance in Prostate Cancer. Drug-resistant aggressive prostate cancer is a major clinical challenge and her lab uses the latest developments in single-cell technology and will work to develop computer algorithms to probe the architecture of DNA in cells and identify the key proteins that regulate cellular states in treatment-resistant prostate cancer. #CancerResearchWeill Cornell Medicinee

It’s #WorldCancerDay. Join #NYP as we strive to create a cancer-free world for all of our patients and their loved ones affected by cancer. #WeCanICan CC: Weill Cornell Medicine & Columbia University Irving Medical Center

Meyer Cancer Center members and leaders of the International Center for the Study of Breast Cancer Subtypes (ICSBCS), Drs. Lisa Newman and Melissa Davis and their collaborative partner, the Komfo Anoyke Teaching Hospital in Kumasi, Ghana, have raised awareness and increased the understanding of race and ethnicity-related risk factors for developing breast cancer through their pioneering research. Read more about their ongoing global efforts and research findings in recognition of #WorldCancerDay. #IAmAndIWill

Lewis Cantley, Ph.D., Marcus Goncalves, M.D., Ph.D., and Benjamin Hopkins, Ph.D. recently published an article in the New England Journal of Medicine about their work on Phosphatidylinositol 3-Kinase (PI3K) as a key regulatory node in growth-factor signaling across evolution.

Congratulations to Dr. Kristy Richards whose work using a canine model to better understand targeted therapies for lymphoma was highlighted in the November 14, 2018 issue of Nature Outlooks.

"Skin cancer and melanoma risk are associated with the ratio of the anti-carcinogenic eumelanin and the pro-carcinogenic pheomelanin." Read more about Dr. Jonathan Zippin's incredible work in Science Signaling.